CNS|CRO is a pre-clinical contract research company offering models for evaluation of test compounds in a range of neurological disorders including ALS-PDC, epilepsy, neuropathic pain, stroke (focal and global), schizophrenia, and autism spectrum disorder. CNS|CRO also offers a variety of behavioural testing paradigms, with add-on assessments such as in vivo electrophysiology and ultrasonic vocalizations available.